Insider Transactions in Q3 2021 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,296
+1.61%
|
$12,888
$3.88 P/Share
|
|
Sep 23
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
3,000
+8.33%
|
$9,000
$3.88 P/Share
|
|
Sep 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,468
+1.71%
|
$13,404
$3.73 P/Share
|
|
Sep 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.91 P/Share
|
|
Aug 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,241
+1.65%
|
$12,723
$3.93 P/Share
|
|
Aug 13
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,931
+1.94%
|
$14,793
$3.38 P/Share
|
|
Aug 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.25 P/Share
|
|
Jul 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,061
+2.43%
|
$12,122
$2.75 P/Share
|
|
Jul 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,435
+2.63%
|
$12,870
$2.59 P/Share
|
|
Jul 09
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.54 P/Share
|